Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorvardur R Halfdanarson

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Pancreas|June 14, 2017
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine TumorsJonathan R Strosberg, Thorvardur R Halfdanarson, Andrew M Bellizzi, et al.
Neuroendocrinology|September 24, 2020
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus StatementBruno Niederle, Andreas Selberherr, Detlef K Bartsch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
The New England Journal of Medicine|September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine TumorsJennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineJaydira Del Rivero, Kimberly Perez, Erin B Kennedy, et al.
Cancer|April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilotAmye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
JCO Oncology Practice|June 14, 2021
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening StrategiesZhuoer Xie, Antoine N Saliba, Jithma Abeykoon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Neuroendocrine tumors, version 1.2015Matthew H Kulke, Manisha H Shah, Al B Benson, et al.
JCO Precision Oncology|July 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract CancersPriyanshi Shah, Anina Peersen, Vaibhav Sahai, et al.
JCO Oncology Practice|May 9, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineKimberly Perez, Jaydira Del Rivero, Erin B Kennedy, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Pancreas|June 14, 2017
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine TumorsJonathan R Strosberg, Thorvardur R Halfdanarson, Andrew M Bellizzi, et al.
Neuroendocrinology|September 24, 2020
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus StatementBruno Niederle, Andreas Selberherr, Detlef K Bartsch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic AdenocarcinomaAmro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
The New England Journal of Medicine|September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine TumorsJennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2023
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineJaydira Del Rivero, Kimberly Perez, Erin B Kennedy, et al.
Cancer|April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilotAmye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
JCO Oncology Practice|June 14, 2021
Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening StrategiesZhuoer Xie, Antoine N Saliba, Jithma Abeykoon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Neuroendocrine tumors, version 1.2015Matthew H Kulke, Manisha H Shah, Al B Benson, et al.
JCO Precision Oncology|July 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract CancersPriyanshi Shah, Anina Peersen, Vaibhav Sahai, et al.
JCO Oncology Practice|May 9, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO GuidelineKimberly Perez, Jaydira Del Rivero, Erin B Kennedy, et al.
Pageof 22